As of February 26, 2026, Robinhood Markets (NASDAQ: HOOD) has officially shed its reputation as a mere "meme stock" gateway, completing a multi-year transformation into a diversified financial "SuperApp." Once synonymous with the retail trading frenzy of 2021, the Menlo Park-based fintech has matured into a profitable powerhouse, challenging established giants like Charles Schwab and [...]
As of February 26, 2026, the digital asset landscape is witnessing a profound maturation, and at the center of this evolution sits Coinbase Global, Inc. (NASDAQ: COIN). Recently, the company captured the attention of Wall Street and retail investors alike with a sharp 13% climb in its stock price following its Q4 2025 earnings report. [...]
As of February 26, 2026, the biotechnology sector is witnessing a historic maturation. For years, the industry narrative was dominated by high-burn, pre-revenue innovators searching for a "blockbuster" that could sustain their independence. Today, Argenx (NASDAQ: ARGX) has effectively ended that search, cementing its status as a global biopharmaceutical powerhouse. Following its full-year 2025 earnings [...]
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations.
However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.
SAN FRANCISCO — February 24, 2026 — The software sector is reeling from a historic collapse as a "Black February" sell-off has officially wiped out more than $1 trillion in market capitalization from the industry in 2026 alone. What began as a simmering anxiety over AI displacement has boiled over into a
Fidelity National Information Services (NYSE: FIS), a global leader in financial services technology, reported robust full-year 2025 financial results on February 24, 2026, meeting its aggressive growth targets and setting a optimistic tone for the year ahead. The company achieved a 6% increase in adjusted revenue and a notable 10%
George Noble, who ran the number one mutual fund in America at Fidelity Investments in 1985 returning 79%, went on Steve Eisman’s Real Eisman Playbook podcast and didn’t hold back.
As of February 23, 2026, the biotechnology landscape has shifted away from the speculative fervor of the early 2020s toward a demand for commercial execution and sustainable revenue. Standing at the center of this transformation is Axsome Therapeutics (Nasdaq: AXSM), a mid-cap CNS (Central Nervous System) specialist that has successfully navigated the "valley of death" [...]
In a definitive display of operational resilience and strategic foresight, Fidelity National Financial (NYSE: FNF) reported its fourth-quarter and full-year 2025 results on February 20, 2026, signaling a major pivot from defensive efficiency to aggressive market expansion. Despite a complex macroeconomic landscape characterized by fluctuating mortgage rates over the past
